Apollo Hospitals Enterprise Limited has reported its financial results for the quarter and half year ended September 30, 2024 (Q2 FY 2025). On November 7, 2024, Apollo Hospitals share price opened at ₹7,316.50, up from its previous close of ₹6,968.10. At 10:04 AM, the share price of Apollo Hospitals was trading at ₹7,452.15, up by 6.95%.
In the quarter the company’s consolidated revenues grew by 15% year-on-year to ₹5,589 crore. The consolidated EBITDA showed a 30% increase, reaching ₹816 crore.
Its Profit After Tax (PAT) surged by 63% year-on-year, totalling ₹379 crore, compared to ₹233 crore in Q2 FY24.
Apollo Hospitals reported consolidated H1 FY25 performance with revenues reaching ₹1,06,749 million, a 15% increase from ₹92,647 million in H1 FY24. EBITDA rose to ₹14,906 million compared to ₹11,365 million in H1 FY24, which includes the cost for Apollo 24/7 amounting to ₹2,849 million (with ₹352 million attributed to non-cash ESOP charges), down from ₹4,012 million in H1 FY24.
The company’s reported PAT also saw significant growth, reaching ₹6,840 million, up from ₹3,995 million in H1 FY24.
In line with its mission to enhance healthcare accessibility, Apollo Hospitals has entered a definitive agreement to build and operate a new 500-bed hospital in Worli, Mumbai, dedicated to providing quality healthcare for the people of Maharashtra. This new facility will mark a significant expansion in the Mumbai region.
Additionally, Apollo Hospitals announced plans to scale up its existing Lucknow facility from 300 to 500 beds by adding 200 beds on newly acquired 1.2-acre land, enhancing capacity and addressing growing healthcare demands in Uttar Pradesh.
With these developments, Apollo Hospitals now aims to add over 3,512 total beds, with 2,877 census beds, over the next four years across 11 different locations throughout India.
Commenting on the performance, the Founder and Chairman of Apollo Hospitals Group, Dr Prathap C Reddy, said, “At Apollo Hospitals, we are dedicated to continually evolving to meet the changing healthcare needs of our nation. Through strategic initiatives like our investment in Apollo Health and Lifestyle and the launch of new multi-speciality hospitals, we reaffirm our commitment to expanding access to high-quality healthcare across India, particularly in regions where critical care access is essential.”
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates
Enjoy ₹0 Account Opening Charges
Join our 2 Cr+ happy customers